Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
2.
J Surg Res ; 232: 128-136, 2018 12.
Article in English | MEDLINE | ID: mdl-30463708

ABSTRACT

BACKGROUND: The objective of this study was to determine acyl-CoA synthetase 5 (ACSL5) and Wnt2B expression patterns in human congenital pulmonary airway malformations (CPAMs) and to identify the possible roles of ACSL5 and Wnt2B in the pathogenesis of CPAM. METHODS: Expression of ACSL5 and Wnt2B was evaluated by immunohistochemical staining, Western blotting, and quantitative real-time polymerase chain reaction, which were performed on surgical specimens of CPAM and adjacent normal lung tissues as controls. RESULTS: Immunohistochemistry revealed that ACSL5 and Wnt2B immunopositive cells were predominantly detected in the mesenchymal cell nucleus, and there were lower expressions of ACSL5 and Wnt2B immunopositive cells in CPAM tissues than those in adjacent normal lung tissues. Western blotting and quantitative real-time polymerase chain reaction showed that ACSL5 and Wnt2B protein and mRNA expressions were significantly decreased in CPAM tissues as compared to the adjacent normal lung tissues (P < 0.05). In addition, there was a reduced level of ACSL5 relative to that of Wnt2B. CONCLUSIONS: The decreased ACSL5 and Wnt2B expressions correlated with aberrations in pulmonary development and in the pathogenesis of CPAM, so downregulation of ACSL5 and Wnt2B could play an important role in the development of bronchial-alveolar structures in CPAM.


Subject(s)
Coenzyme A Ligases/genetics , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Glycoproteins/genetics , Wnt Proteins/genetics , Coenzyme A Ligases/analysis , Coenzyme A Ligases/physiology , Glycoproteins/analysis , Glycoproteins/physiology , Humans , Immunohistochemistry , RNA, Messenger/analysis , Wnt Proteins/analysis , Wnt Proteins/physiology
3.
Eur J Pediatr ; 176(12): 1559-1571, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29046943

ABSTRACT

Congenital pulmonary airway malformations or CPAM are rare developmental lung malformations, leading to cystic and/or adenomatous pulmonary areas. Nowadays, CPAM are diagnosed prenatally, improving the prenatal and immediate postnatal care and ultimately the knowledge on CPAM pathophysiology. CPAM natural evolution can lead to infections or malignancies, whose exact prevalence is still difficult to assess. The aim of this "state-of-the-art" review is to cover the recently published literature on CPAM management whether the pulmonary lesion was detected during pregnancy or after birth, the current indications of surgery or surveillance and finally its potential evolution to pleuro-pulmonary blastoma. CONCLUSION: Surgery remains the cornerstone treatment of symptomatic lesions but the postnatal management of asymptomatic CPAM remains controversial. There are pros and cons of surgical resection, as increasing rate of infections over time renders the surgery more difficult after months or years of evolution, as well as risk of malignancy, though exact incidence is still unknown. What is known: • Congenital pulmonary airway malformations (CPAM) are rare developmental lung malformations mainly antenatally diagnosed. • While the neonatal management of symptomatic CPAM is clear and includes prompt surgery, controversies remain for asymptomatic CPAM due to risk of infections and malignancies. What is new: • Increased rate of infection over time renders the surgery more difficult after months or years of evolution and pushes for recommendation of early elective surgery. • New molecular or pathological pathways may help in the distinction of type 4 CPAM from type I pleuropulmonary blastoma.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/pathology , Cystic Adenomatoid Malformation of Lung, Congenital/therapy , Disease Progression , Female , Genetic Predisposition to Disease , Humans , Lung/abnormalities , Lung/embryology , Lung Neoplasms/diagnosis , Lung Neoplasms/etiology , Lung Neoplasms/therapy , Pediatrics , Pregnancy , Prenatal Diagnosis , Pulmonary Blastoma/diagnosis , Pulmonary Blastoma/etiology , Pulmonary Blastoma/therapy
4.
Early Hum Dev ; 90(12): 935-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25448785

ABSTRACT

Congenital cystic lesions of the lung are present in 1 in 10,000-35,000 births and present as a spectrum of anomalies. Majority of these cystic lesions comprise congenital cystic adenomatoid malformations, pulmonary sequestrations, congenital lobar emphysema, and bronchogenic cysts. Most of these lesions are nowadays detected antenatally, however some will present either in the newborn or during later childhood. A review of the aetiology, classification, natural history, investigations, and treatment of congenital cystic lung lesions is discussed.


Subject(s)
Lung Diseases/therapy , Lung/abnormalities , Bronchogenic Cyst/diagnosis , Bronchogenic Cyst/etiology , Bronchogenic Cyst/therapy , Bronchopulmonary Sequestration/diagnosis , Bronchopulmonary Sequestration/etiology , Bronchopulmonary Sequestration/therapy , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/therapy , Guidelines as Topic , Humans , Infant, Newborn , Lung Diseases/diagnosis , Lung Diseases/etiology , Pulmonary Emphysema/congenital , Pulmonary Emphysema/diagnosis , Pulmonary Emphysema/etiology , Pulmonary Emphysema/therapy
5.
J Matern Fetal Neonatal Med ; 27(3): 228-32, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23697759

ABSTRACT

OBJECTIVE: To identify the incidence of congenital cystic adenomatoid malformation of the lung (CCAM) at birth; to evaluate prenatal and perinatal history, association with clinical and sociodemographic variables and concordance between CT scan results and anatomopathology studies. METHOD: Descriptive study based on the registry of malformed newborns, deliveries and patients records between August 1990 and November 2010. Ultrasonic, clinical, imaging and anatomopathologic information were studied. Association studies were made using chi-square test. Kappa was used to correlate CT scan to anatomopathology results. RESULTS: The incidence was 1:1980 (25/49 503). The mean gestational age for detection by ultrasonography was 24 ± 3.7 weeks. There were progression of the lesions in 11 cases (44%), stability in 6 (24%) and regression in 8 (32%). Three cases of CCAM followed due to polyhydramnios/hydrops died. There were neither familial cases nor association with sex, weight, age or maternal parity (p > 0.15). Radiographic abnormalities were found in 22/23 studied patients. The correspondence between CT scan and anatomopathologic was 0.77 (Kappa). CONCLUSIONS: The incidence was higher than the one described in the literature, probably, because it is a reference center in fetal medicine. The prenatal lesion involution rate was 32%, an intermediate proportion. There was good concordance between CT scan and anatomopathologic results. The polyhydramnios/hydrops were predictive of worst prognosis.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Brazil/epidemiology , Cystic Adenomatoid Malformation of Lung, Congenital/epidemiology , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/therapy , Female , Fetal Therapies , Follow-Up Studies , Humans , Incidence , Infant, Newborn , Male , Pregnancy , Registries , Remission, Spontaneous , Risk Factors , Tomography, X-Ray Computed , Ultrasonography, Prenatal
6.
Rev Pneumol Clin ; 69(4): 190-7, 2013 Aug.
Article in French | MEDLINE | ID: mdl-23850268

ABSTRACT

Congenital cystic adenomatoid malformations (CCAM) of the lung are the most frequent congenital lung malformations. Their diagnosis is based on histological features. CCAM consist of bronchopulmonary cystic lesions which are classified according to the presence and cysts size. Type I CCAM are composed of large cysts (>2 cm) lined by a columnar pseudostratified epithelium. Type II CCAM contain multiple small cystic lesions (<1 cm) lined by a flattened cuboidal epithelium. Type III CCAM are more solid and contain immature structures resembling the pseudoglandular stage of lung development. Ultrasonography (US) allows early detection during the second trimester of pregnancy as cystic, and/or hyperechoic fetal lung lesions. Although most CCAM remain asymptomatic, CCAM can cause polyhydramnios or fetal hydrops, respiratory distress at birth, infections and pneumothoraces during infancy, and may give rise to malignancies. Serial US allow detection of complications, and planification of delivery. Complicated forms require an urgent treatment. In fetuses with a macrocystic life-threatening lesion, a thoraco-amniotic shunt can be placed. Microcystic compressive forms may respond to prenatal steroids. Post-natal symptomatic lesions require early surgery. The treatment of asymptomatic forms remains controversial. Some recommend a non-operative approach with a long-term clinical and radiological following, whereas other favour a preventive surgical excision. The origin of CCAM remains unknown. Recent advances suggest a transient and focal abnormality in lung development which may result from an airway obstruction. This article reviews the diagnosis, treatment, and pathophysiology of CCAM.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital , Age Factors , Child, Preschool , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/therapy , Female , Fetoscopy/methods , Humans , Infant , Infant, Newborn , Pneumonectomy/statistics & numerical data , Pregnancy , Prenatal Diagnosis
7.
Rev Mal Respir ; 29(4): 601-11, 2012 Apr.
Article in French | MEDLINE | ID: mdl-22542416

ABSTRACT

INTRODUCTION: Congenital lung lesions comprise a broad spectrum of various malformations including congenital cystic adenomatoid malformation (CCAM), bronchopulmonary sequestration (BPS), congenital lobar emphysema, bronchial atresia and bronchogenic cyst. This review aims at the description of their natural history, and of the underlying pathophysiological mechanisms. STATE OF THE ART: Congenital lung lesions are frequently diagnosed antenatally and many remain asymptomatic after birth. In the absence of antenatal identification, they are usually revealed by the occurrence of infection. In some cases, spontaneous resolution of the malformation can occur. Different pathogenic hypotheses are discussed for the origin of these abnormalities, and common processes appear likely to all of these malformations. Factors involved in the process of branching seem to play a particularly important role. PERSPECTIVES: Prospective follow-up of operated and unoperated children would complete our knowledge about the natural history of these lesions. The contribution of experimental models has led to advances in the understanding of pathogenic mechanisms. Further studies are needed to identify the factors initiating the malformative process.


Subject(s)
Lung Diseases/congenital , Lung/abnormalities , Respiratory System Abnormalities/etiology , Bronchopulmonary Sequestration/diagnosis , Bronchopulmonary Sequestration/etiology , Bronchopulmonary Sequestration/genetics , Bronchopulmonary Sequestration/therapy , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/genetics , Cystic Adenomatoid Malformation of Lung, Congenital/therapy , Disease Progression , Humans , Lung Diseases/complications , Lung Diseases/genetics , Lung Diseases/pathology , Models, Biological , Respiratory System Abnormalities/complications , Respiratory System Abnormalities/genetics , Respiratory System Abnormalities/pathology
8.
MULTIMED ; 11(3)2007.
Article in Spanish | CUMED | ID: cum-40620

ABSTRACT

Se presenta el caso de un lactante, parto fuera de la maternidad, ingresado en el Servicio de Pediatría por tos, discreta dificultad respiratoria, fiebre y disminución del peso para su edad, que luego del interrogatorio a la madre sobre sus síntomas a partir del nacimiento y las radiografías simples y contrastadas se llega a la conclusión de tratarse de una anomalía congénita del pulmón llamada malformación quística adenomatoidea, entidad muy rara caracterizada por quistes pulmonares únicos o múltiples limitándose a un lóbulo del pulmón y que se presentan en niños desde el período neonatal, se describe el cuadro clínico y radiológico del paciente.(AU)


We present a case report of a breast-fed whild which delivery was out of a lying in hospital admitted to Pediatric service suffering from cough, a discrete respiratory distress, fever, and decreased weight for its age. After the mother´s interrogatpry about its symptoms from delivery, and simple and contrasted X rays, it is concluded it is a lung congenital anomaly colled adenomatoid cystic malformation, a very rare entity characterized by unique on multiple lung cysts, limited to a lung lobule, which is presented in children from neonatal period on. Clinical and radiologic findings of the patient are described.(EU)


Subject(s)
Humans , Male , Female , Lung , Cystic Adenomatoid Malformation of Lung, Congenital/drug therapy , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/etiology
9.
Fetal Diagn Ther ; 20(5): 472-4, 2005.
Article in English | MEDLINE | ID: mdl-16113577

ABSTRACT

We present a case of congenital cystic adenomatoid malformation of the lung diagnosed at 34 weeks of gestation in the setting of polyhydramnios. The fetus had CCAM in the L lung, with mediastinal shift to the right and ascites. The neonate underwent drainage of cysts and subsequent left lung lobar resection with improvement in respiratory function. The pathology of CCAM is reviewed in detail. We speculate the role of alcohol as a teratogen through retinoic acid at 8-10 weeks of gestation when fetal lungs are actively developing.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/diagnostic imaging , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Fetal Alcohol Spectrum Disorders/diagnostic imaging , Acute Disease , Adult , Female , Fetal Alcohol Spectrum Disorders/metabolism , Humans , Polyhydramnios/diagnostic imaging , Polyhydramnios/etiology , Pregnancy , Pregnancy Trimester, Third , Tretinoin/metabolism , Ultrasonography, Prenatal
10.
Prenat Diagn ; 23(12): 997-1002, 2003 Dec 15.
Article in English | MEDLINE | ID: mdl-14663837

ABSTRACT

OBJECTIVES: Most available data regarding accuracy of prenatal diagnosis, prevalence and outcome of congenital cystic adenomatoid malformation (CCAM) are derived largely from tertiary referral centres and may not reflect general population rates. We aimed to describe the accuracy of prenatal diagnosis, ascertain the population prevalence and post-natal outcome for cases of suspected CCAM. METHODS: Retrospective collection of prenatal and paediatric data for cases of suspected CCAM notified to the Trent Congenital Anomalies Register 1997 to 2001. RESULTS: Thirty-seven cases of CCAM were suspected prenatally. Twenty-one cases were confirmed post-natally as having a CCAM (positive predictive value 57%). Eighteen of the 21 cases were delivered at term as live births, 15 of which have undergone successful surgery to date. Thirteen of the 37 cases had apparently resolved by delivery. Three further cases were subsequently found to be cases of lung sequestration or lobar emphysema. Five cases of CCAM were detected after delivery (sensitivity of prenatal detection 81%). The population prevalence at delivery was 9.0 per 1,00,000 total births. Five confirmed cases of CCAM developed hydrops, three required in utero intervention and delivered as live births at term, one was terminated and one died in utero. The overall mortality in the confirmed cases of CCAM was 23% of which the majority were terminations of pregnancy. CONCLUSIONS: Problems of diagnostic accuracy and apparent resolution of CCAM render counselling difficult, although our data suggest that the prognosis is better than others have reported. Confirmation of the diagnosis in the neonatal period is vital in order to obtain the true population prevalence figures and to interpret outcome data.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/diagnostic imaging , Cystic Adenomatoid Malformation of Lung, Congenital/epidemiology , Ultrasonography, Prenatal/standards , Adult , Cystic Adenomatoid Malformation of Lung, Congenital/embryology , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , England/epidemiology , Female , Gestational Age , Humans , Medical Records , Predictive Value of Tests , Pregnancy , Pregnancy Outcome , Prevalence , Registries , Retrospective Studies , Sensitivity and Specificity
11.
Pediatr Pathol Lab Med ; 16(4): 637-42, 1996.
Article in English | MEDLINE | ID: mdl-9025860

ABSTRACT

This case report describes an infra-diaphragmatic sequestrated type II congenital cystic adenomatoid malformation (CCAM) containing striated muscle fibers in the stroma occurring in association with an extra-lobar sequestration (ELS) and a congenital diaphragmatic hernia in a female neonate. The classification and pathogenesis of CCAM and ELS are reviewed and the relationships between these lesions discussed.


Subject(s)
Bronchopulmonary Sequestration/etiology , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Hernia, Diaphragmatic/complications , Hernias, Diaphragmatic, Congenital , Female , Humans , Infant, Newborn
12.
Mod Pathol ; 8(9): 913-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8751331

ABSTRACT

Congenital cystic adenomatoid malformation (CCAM) encompasses a spectrum of variably cystic developmental anomalies of the lung histologically characterized by immature lung tissue. The pathogenesis is uncertain, but many investigators favor a maturation arrest in bronchopulmonary development. To investigate this hypothesis, the vascular development and proliferation capacity of lung tissue with CCAM type I from nine infants ranging in age from 20 weeks gestation to 42 days old were studied immunohistochemically utilizing CD34 for the former and MIB-1 for the latter. Both markers were quantitated on an image analysis system. CCAM was hypovascular with a mean vascular index of 20.05% +/- 6.58 compared to 40.06% +/- 4.19 for the age-matched controls (P < 0.000001). The proliferation index of both epithelial and mesenchymal components was higher in CCAM (10.46 +/- 3.48) than in control tissue (7.14 +/- 1.88; P < 0.012). In contrast to the control lung tissue which showed a remarkable synchrony between the vascular development and proliferation throughout the parenchyma, focal asynchrony between the proliferation of the epithelial and stromal components was noted in CCAM. The vascularity in CCAM corresponds to that seen in early gestation. The cellular proliferation in CCAM is higher than in full-term infants and corresponds to late second trimester or early third trimester fetuses. These findings support the proposed pathogenesis of a maturation defect in lung embryogenesis.


Subject(s)
Blood Vessels/pathology , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Lung/blood supply , Antigens, CD34/analysis , Antigens, CD34/immunology , Antigens, Nuclear , Biomarkers/analysis , Blood Vessels/growth & development , Child, Preschool , Cystic Adenomatoid Malformation of Lung, Congenital/embryology , Cystic Adenomatoid Malformation of Lung, Congenital/metabolism , Cystic Adenomatoid Malformation of Lung, Congenital/pathology , Female , Gestational Age , Humans , Immunohistochemistry , Infant , Infant, Newborn , Ki-67 Antigen , Lung/chemistry , Nuclear Proteins/biosynthesis , Nuclear Proteins/immunology , Pregnancy
14.
Histopathology ; 21(4): 315-21, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1398534

ABSTRACT

Congenital cystic adenomatoid malformation is a rare developmental abnormality of the lung. In most earlier reported cases, the anatomy of the bronchial tree was poorly documented. We describe four cases studied following autopsy. Post-mortem bronchography or serial microscopical examination showed segmental bronchial absence or atresia in each of them. Our observations provide further evidence pointing to bronchial atresia as being the primary defect leading to the development of congenital cystic adenomatoid malformation. The morphology of the lesion, i.e. the type of malformation, is determined by the extent of dysplastic lung growth beyond the atretic segment. The aetiology of the bronchial atresia is probably heterogeneous and may either represent a primary malformation, or be the result of vascular disruption.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/embryology , Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Autopsy , Cystic Adenomatoid Malformation of Lung, Congenital/pathology , Female , Fetal Diseases/etiology , Fetal Diseases/pathology , Humans , Male
15.
Am J Surg ; 163(5): 510-4, 1992 May.
Article in English | MEDLINE | ID: mdl-1575309

ABSTRACT

Congenital cystic adenomatoid malformation (CCAM) is a regional overgrowth of bronchioles with suppression of alveolar development in fetal and newborn lung. Twelve patients with CCAM were treated. Six premature infants had acute respiratory distress. Prenatal ultrasound was performed in only five patients and was abnormal in all five. Five premature neonates also had patent ductus arteriosus complicating their courses. Six older children presented with recurrent pneumonitis. Radiographs showed asymmetry of the chest and radiolucent masses in all 12 patients. Seven had type I lesions, two had type II lesions, and three had type III lesions. Hydramnios and hydrops were present in three, and hydrops alone was present in one of the six neonates. These four patients died. One other neonate died of respiratory failure and persistent fetal circulation. Seven patients survived for an extended period. Ultrasound makes the prenatal diagnosis of hydramnios and hydrops possible. It is in this group that fetal interventions can be considered. For the remaining patients, surgical intervention is indicated at the time of diagnosis.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/etiology , Hydrops Fetalis/complications , Polyhydramnios/complications , Child , Child, Preschool , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/pathology , Female , Humans , Infant , Infant, Newborn , Male , Pregnancy , Prenatal Diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...